Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Bien, CG; Elger, CE
   Monotherapy trials in antiepileptic drugs: are modified "presurgical studies" a way out of the dilemma?
   EPILEPSY RESEARCH
   
   C.G. Bien e C.E. Elger, "Monotherapy trials in antiepileptic drugs: are modified "presurgical studies" a way out of the dilemma?", EPILEPSY R, 44(1), 2001, pp. 1-5
2. Sachdeo, R; Beydoun, A; Schachter, S; Vazquez, B; Schaul, N; Mesenbrink, P; Kramer, L; D'Souza, J
   Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures
   NEUROLOGY
   
   R. Sachdeo et al., "Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures", NEUROLOGY, 57(5), 2001, pp. 864-871
3. Beydoun, A; Sachdeo, RC; Rosenfeld, WE; Krauss, GL; Sessler, N; Mesenbrink, P; Kramer, L; D'Souza, J
   Oxcarbazepine monotherapy for partial-onset seizures - A multicenter, double-blind, clinical trial
   NEUROLOGY
   
   A. Beydoun et al., "Oxcarbazepine monotherapy for partial-onset seizures - A multicenter, double-blind, clinical trial", NEUROLOGY, 54(12), 2000, pp. 2245-2251
4. Laxer, K; Blum, D; Abou-Khalil, BW; Morrell, MJ; Lee, DA; Data, JL; Monaghan, EP
   Assessment of ganaxolone's anticonvulsant activity using a randomized, double-blind, presurgical trial design
   EPILEPSIA
   
   K. Laxer et al., "Assessment of ganaxolone's anticonvulsant activity using a randomized, double-blind, presurgical trial design", EPILEPSIA, 41(9), 2000, pp. 1187-1194
5. Ben-Menachem, E; Falter, T
   Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: A multicenter, double-blind, responder-selected study evaluating monotherapy
   EPILEPSIA
   
   E. Ben-Menachem e T. Falter, "Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: A multicenter, double-blind, responder-selected study evaluating monotherapy", EPILEPSIA, 41(10), 2000, pp. 1276-1283
6. Perucca, E; Tomson, T
   Monotherapy trials with the new antiepileptic drugs: study designs, practical relevance and ethical implications
   EPILEPSY RESEARCH
   
   E. Perucca e T. Tomson, "Monotherapy trials with the new antiepileptic drugs: study designs, practical relevance and ethical implications", EPILEPSY R, 33(2-3), 1999, pp. 247-262
7. Pellock, JM; Appleton, R
   Use of new antiepileptic drugs in the treatment of childhood epilepsy
   EPILEPSIA
   
   J.M. Pellock e R. Appleton, "Use of new antiepileptic drugs in the treatment of childhood epilepsy", EPILEPSIA, 40, 1999, pp. S29-S38
8. PERUCCA E
   INNOVATIVE MONOTHERAPY TRIAL DESIGNS FOR THE ASSESSMENT OF ANTIEPILEPTIC DRUGS - A CRITICAL-APPRAISAL
   European Journal of Clinical Pharmacology
   
   E. Perucca, "INNOVATIVE MONOTHERAPY TRIAL DESIGNS FOR THE ASSESSMENT OF ANTIEPILEPTIC DRUGS - A CRITICAL-APPRAISAL", European Journal of Clinical Pharmacology, 54(1), 1998, pp. 1-5
9. BAKER GA; CAMFIELD C; CAMFIELD P; CRAMER JA; ELGER CE; JOHNSON AL; DASILVA AM; MEINARDI H; MUNARI C; PERUCCA E; THORBECKE R
   COMMISSION ON OUTCOME MEASUREMENT IN EPILEPSY, 1994-1997 - FINAL REPORT
   Epilepsia
   
   G.A. Baker et al., "COMMISSION ON OUTCOME MEASUREMENT IN EPILEPSY, 1994-1997 - FINAL REPORT", Epilepsia, 39(2), 1998, pp. 213-231
10. SIRVEN JI
    EPILEPSY IN OLDER ADULTS - CAUSES, CONSEQUENCES AND TREATMENT
    Journal of the American Geriatrics Society
    
    J.I. Sirven, "EPILEPSY IN OLDER ADULTS - CAUSES, CONSEQUENCES AND TREATMENT", Journal of the American Geriatrics Society, 46(10), 1998, pp. 1291-1301
11. PERUCCA E
    EVALUATION OF DRUG-TREATMENT OUTCOME IN EPILEPSY - A CLINICAL PERSPECTIVE
    Pharmacy world & science
    
    E. Perucca, "EVALUATION OF DRUG-TREATMENT OUTCOME IN EPILEPSY - A CLINICAL PERSPECTIVE", Pharmacy world & science, 19(5), 1997, pp. 217-222
12. CHAPMAN DP; GILES WH
    PHARMACOLOGICAL AND DIETARY THERAPIES IN EPILEPSY - CONVENTIONAL TREATMENTS AND RECENT ADVANCES
    Southern medical journal
    
    D.P. Chapman e W.H. Giles, "PHARMACOLOGICAL AND DIETARY THERAPIES IN EPILEPSY - CONVENTIONAL TREATMENTS AND RECENT ADVANCES", Southern medical journal, 90(5), 1997, pp. 471-480
13. SIRVEN JI; LIPORACE JD
    NEW ANTIEPILEPTIC DRUGS - OVERCOMING THE LIMITATIONS OF TRADITIONAL THERAPY
    Postgraduate medicine
    
    J.I. Sirven e J.D. Liporace, "NEW ANTIEPILEPTIC DRUGS - OVERCOMING THE LIMITATIONS OF TRADITIONAL THERAPY", Postgraduate medicine, 102(1), 1997, pp. 147
14. BERGEY GK; MORRIS HH; ROSENFELD W; BLUME WT; PENOVICH PE; MORRELL MJ; LEIDERMAN DB; CROCKATT JG; LAMOREAUX L; GAROFALO E; PIERCE M
    GABAPENTIN MONOTHERAPY .1. AN 8-DAY, DOUBLE-BLIND, DOSE-CONTROLLED, MULTICENTER STUDY IN HOSPITALIZED-PATIENTS WITH REFRACTORY COMPLEX PARTIAL OR SECONDARILY GENERALIZED SEIZURES
    Neurology
    
    G.K. Bergey et al., "GABAPENTIN MONOTHERAPY .1. AN 8-DAY, DOUBLE-BLIND, DOSE-CONTROLLED, MULTICENTER STUDY IN HOSPITALIZED-PATIENTS WITH REFRACTORY COMPLEX PARTIAL OR SECONDARILY GENERALIZED SEIZURES", Neurology, 49(3), 1997, pp. 739-745
15. FRENCH JA
    WHAT TRIALS, WHICH DESIGNS
    Epilepsia
    
    J.A. French, "WHAT TRIALS, WHICH DESIGNS", Epilepsia, 38(3), 1997, pp. 263-265
16. BARRON TF; HUNT SL
    A REVIEW OF THE NEWER ANTIEPILEPTIC DRUGS AND THE KETOGENIC DIET
    Clinical pediatrics
    
    T.F. Barron e S.L. Hunt, "A REVIEW OF THE NEWER ANTIEPILEPTIC DRUGS AND THE KETOGENIC DIET", Clinical pediatrics, 36(9), 1997, pp. 513-521
17. WILSON EA; BRODIE MJ
    NEW ANTIEPILEPTIC DRUGS
    Bailliere's clinical neurology
    
    E.A. Wilson e M.J. Brodie, "NEW ANTIEPILEPTIC DRUGS", Bailliere's clinical neurology, 5(4), 1996, pp. 723-747
18. SCHMIDT D
    RATIONAL POLYTHERAPY
    Bailliere's clinical neurology
    
    D. Schmidt, "RATIONAL POLYTHERAPY", Bailliere's clinical neurology, 5(4), 1996, pp. 757-763
19. WILDER BJ
    ANTIEPILEPTIC DRUGS - CURRENT USE
    Canadian journal of neurological sciences
    
    B.J. Wilder, "ANTIEPILEPTIC DRUGS - CURRENT USE", Canadian journal of neurological sciences, 23(4), 1996, pp. 18-23
20. DICHTER MA; BRODIE MJ
    DRUG-THERAPY - NEW ANTIEPILEPTIC DRUGS
    The New England journal of medicine
    
    M.A. Dichter e M.J. Brodie, "DRUG-THERAPY - NEW ANTIEPILEPTIC DRUGS", The New England journal of medicine, 334(24), 1996, pp. 1583-1590
21. BENBADIS SR; LUDERS HO
    EPILEPTIC SYNDROMES - AN UNDERUTILIZED CONCEPT
    Epilepsia
    
    S.R. Benbadis e H.O. Luders, "EPILEPTIC SYNDROMES - AN UNDERUTILIZED CONCEPT", Epilepsia, 37(11), 1996, pp. 1029-1034
22. GRAM L
    PHARMACOKINETICS OF NEW ANTIEPILEPTIC DRUGS
    Epilepsia
    
    L. Gram, "PHARMACOKINETICS OF NEW ANTIEPILEPTIC DRUGS", Epilepsia, 37, 1996, pp. 12-16
23. WILLMORE LJ
    MANAGEMENT OF EPILEPSY IN THE ELDERLY
    Epilepsia
    
    L.J. Willmore, "MANAGEMENT OF EPILEPSY IN THE ELDERLY", Epilepsia, 37, 1996, pp. 23-33
24. DICHTER MA
    INTEGRATED USE OF OLD AND NEW ANTIEPILEPTIC DRUGS
    Current opinion in neurology
    
    M.A. Dichter, "INTEGRATED USE OF OLD AND NEW ANTIEPILEPTIC DRUGS", Current opinion in neurology, 8(2), 1995, pp. 95-102
25. SCHMIDT D; GRAM L
    MONOTHERAPY VERSUS POLYTHERAPY IN EPILEPSY - A REAPPRAISAL
    CNS DRUGS
    
    D. Schmidt e L. Gram, "MONOTHERAPY VERSUS POLYTHERAPY IN EPILEPSY - A REAPPRAISAL", CNS DRUGS, 3(3), 1995, pp. 194-208
26. WILDER BJ
    THE TREATMENT OF EPILEPSY - AN OVERVIEW OF CLINICAL PRACTICES
    Neurology
    
    B.J. Wilder, "THE TREATMENT OF EPILEPSY - AN OVERVIEW OF CLINICAL PRACTICES", Neurology, 45(3), 1995, pp. 7-11
27. PELLOCK JM
    ANTIEPILEPTIC DRUG-THERAPY IN THE UNITED-STATES - A REVIEW OF CLINICAL-STUDIES AND UNMET NEEDS
    Neurology
    
    J.M. Pellock, "ANTIEPILEPTIC DRUG-THERAPY IN THE UNITED-STATES - A REVIEW OF CLINICAL-STUDIES AND UNMET NEEDS", Neurology, 45(3), 1995, pp. 17-24
28. MATSUMOTO RR; NGUYEN DC; TRUONG DD
    STRYCHNINE-INSENSITIVE GLYCINE SITE ANTAGONISTS ATTENUATE A CARDIAC ARREST-INDUCED MOVEMENT DISORDER
    European journal of pharmacology
    
    R.R. Matsumoto et al., "STRYCHNINE-INSENSITIVE GLYCINE SITE ANTAGONISTS ATTENUATE A CARDIAC ARREST-INDUCED MOVEMENT DISORDER", European journal of pharmacology, 275(2), 1995, pp. 117-123
29. PLEDGER GW; SCHMIDT D
    EVALUATION OF ANTIEPILEPTIC DRUG EFFICACY - A REVIEW OF CLINICAL-TRIAL DESIGN
    Drugs
    
    G.W. Pledger e D. Schmidt, "EVALUATION OF ANTIEPILEPTIC DRUG EFFICACY - A REVIEW OF CLINICAL-TRIAL DESIGN", Drugs, 48(4), 1994, pp. 498-509